Kimberly Clark CORP

Kimberly-Clark announced second quarter 2026 results with net sales of $4.2 billion, driven by innovation and productivity, while updating its 2026 outlook.

Kimberly-Clark Corporation held its 2026 Annual Meeting of Stockholders, where directors were elected, auditors ratified, and executive compensation approved, though a proposal for an independent Board Chair was not approved.

Kimberly-Clark announced first quarter 2026 results, showing net sales growth and reaffirming its full-year outlook, driven by innovation and productivity.

Kimberly-Clark and Kenvue shareholders overwhelmingly approved all proposals for Kimberly-Clark's acquisition of Kenvue, moving closer to creating a global health and wellness leader.

Kimberly-Clark reported strong fourth-quarter and full-year 2025 results, driven by its transformation strategy and anticipating further momentum from the Kenvue acquisition.

Kimberly-Clark Corporation filed an 8-K to supplement its joint proxy statement/prospectus regarding its merger with Kenvue Inc., addressing multiple stockholder lawsuits alleging material omissions.

Kimberly-Clark Corporation announced its second quarter 2026 financial results, highlighting a 0.6% increase in net sales and a significant strategic milestone with the completion of the IFP Transaction.

Kimberly-Clark Corporation announced its first-quarter 2026 financial results, showcasing a 2.7% increase in net sales driven by organic growth and favorable currency impacts, while also providing updates on its pending acquisition of Kenvue.

Kimberly-Clark reported a significant decline in Q3 2025 net income and EPS, primarily due to a $130 million tax charge from the One Big Beautiful Bill Act, despite modest organic sales growth.

Kimberly-Clark's second quarter 2025 results show a decline in net sales and profitability from continuing operations, impacted by divestitures, currency fluctuations, and cost inflation, while the company progresses with its 2024 Transformation Initiative and the planned International Family Care and Professional (IFP) business joint venture.

Kimberly-Clark's Q1 2025 net sales decreased by 6.0% due to unfavorable currency impacts, divestitures, and strategic pricing investments, despite progress in the 2024 Transformation Initiative.

Kimberly-Clark's third-quarter results show a decrease in net sales but an increase in operating profit, influenced by a transformation initiative and divestitures.

Kimberly-Clark's 2025 annual report details a strategic pivot with the Kenvue acquisition and IFP joint venture, alongside a 2.1% net sales decline and a 12.9% drop in operating profit from continuing operations.

Kimberly-Clark's 2024 results show a significant increase in operating profit and net income, driven by higher gross margins and the sale of its PPE business, despite a slight decrease in net sales.

Kimberly-Clark's 2023 annual report details its common stock structure, anti-takeover provisions, and business performance across its personal care, consumer tissue, and K-C professional segments.

Patricia Corsi, Chief Growth Officer of Kimberly Clark Corp, reported multiple transactions in common stock on July 31, 2026.

Craig Slavtcheff, Chief R&D Officer of Kimberly Clark Corp, reported multiple transactions in common stock on July 31, 2026.

Andrew Scribner, Controller, VP & FP&A at Kimberly Clark Corp, reported a sale of 4,095 shares of common stock on May 6, 2026.

Katy Chen, President of International Personal Care at Kimberly-Clark, reported the vesting of restricted share units and a subsequent sale of shares for tax obligations.

John Patrick Carmichael, President of North America at Kimberly-Clark Corp, reported the acquisition of restricted share units under the company's Equity Participation Plan.

Kimberly-Clark Corp. reports that Chief Human Resources Officer Stacey J. Panayiotou acquired 5,119 restricted share units on May 1, 2026, under the company's Equity Participation Plan.

Kimberly-Clark's 2026 proxy statement details a year of strategic portfolio transformation, including major acquisitions and a joint venture, alongside mixed financial results for 2025.

Kimberly-Clark Corporation will hold its Annual Meeting of Stockholders virtually on May 1, 2025, to vote on the election of directors, ratification of the auditor, and executive compensation.

Kimberly-Clark's 2024 results exceeded expectations amidst macroeconomic headwinds, driven by strong execution of the Powering Care strategy.

Kimberly-Clark Corporation has issued a supplement to its proxy statement clarifying the effect of broker non-votes on Proposal 4, concerning the adoption of an amended and restated certificate of incorporation.

Kimberly-Clark Corporation will hold its Annual Meeting of Stockholders virtually on May 2, 2024, to vote on the election of directors, ratification of the auditor, executive compensation, and amendments to the certificate of incorporation.

Kimberly-Clark's proxy statement highlights a successful 2023 with improved organic growth and margins, alongside changes in board leadership and a focus on sustainability and diversity.

State Street Corporation has reported beneficial ownership of 6.5% of Kimberly-Clark Corp. common stock as of March 31, 2026.

Vanguard Capital Management has reported a beneficial ownership of 7.5% in Kimberly-Clark Corp. common stock as of March 31, 2026.

The Vanguard Group reported zero beneficial ownership in Kimberly-Clark Corp following an internal realignment and disaggregated reporting by its subsidiaries.

The Vanguard Group has filed an amended Schedule 13G, revealing a 12.18% beneficial ownership stake in Kimberly-Clark Corp, totaling over 40 million shares.

BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reaffirming its passive 7.6% beneficial ownership in Kimberly-Clark Corporation as of March 31, 2025.

The Vanguard Group has filed an amended Schedule 13G, reporting a 10.53% beneficial ownership stake in Kimberly-Clark Corp as of December 31, 2024.